Form 8-K Summary
Business Context and Reporting Period
Flora Growth Corp. filed a Form 8-K reporting the completion, on November 1, 2023, of the previously disclosed sale of its Colombian operations and related assets to Lisan Farma Colombia LLC. The filing entity is Flora Growth Corp., not Zerostack Corp. The report was signed on November 3, 2023.
Transaction and Key Assets
- Flora sold shares in Flora Growth Corp. Colombia S.A.S., Flora Lab S.A.S., Flora Med S.A.S., Cosechemos Ya S.A.S., Kasa Wholefoods Company S.A.S., and other related Colombian assets.
- Assets included the lease for the 361-acre Cosechemos farm in Giron, Colombia, including 249 licensed cultivation acres, a processing facility, equipment, structures, and cannabis inventory.
- The transaction also included equipment, licenses, contracts, and certifications associated with Flora Lab 2 and Flora Lab 4 in Bogota.
- All inventory and accounts receivable related to the food and beverage business and Flora Labs S.A.S. were included.
- The assets were transferred to Lisan on an “as is where is” basis under the Share Purchase Agreement, as amended.
Financial Metrics and Liquidity
The filing does not provide transaction consideration, proceeds, gain or loss, revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes, Outlook, and Risks
The completion of the sale represents a material disposition of Flora’s Colombian operations and related cultivation, processing, laboratory, food, beverage, and inventory assets. The filing provides no updated guidance, management outlook, contingency details, or quantified risk assessment.
Important Facts to Verify
- Verify the purchase price, payment terms, and any remaining closing conditions in the Share Purchase Agreement and Amendment No. 1.
- Review subsequent financial statements for the accounting treatment, gain or loss, proceeds received, and discontinued or disposed operations impacts.
- Confirm the specific assets, liabilities, licenses, contracts, inventory, and accounts receivable transferred to Lisan.
- Assess the effect of the disposition on Flora’s remaining business, revenue base, liquidity, and regulatory exposure.
- Note that the supplied request metadata identifies Zerostack Corp., while the filing names Flora Growth Corp. as the registrant.